19/06/2026
Aotearoa New Zealand researchers and clinicians have contributed to a major international clinical trial that is set to change how Staphylococcus aureus bloodstream infections are treated worldwide.
Read more
14/05/2026
ACTT’s quarterly update for our sponsors, partners and collaborators. Sharing key milestones, research activity, business growth, opportunities to engage, and the collective impact made possible through our work together.
Read more
14/05/2026
Despite ongoing global uncertainty, Aotearoa Clinical Trials remains firmly focused on its mission to bring more novel clinical trials and therapies to the communities we serve across Aotearoa New Zealand. Our continued commitment to quality has been recognised, with our sites achieving the highest level of accreditation from the International Accreditation Agency for Clinical Research (IAOCR).
Read more
28/04/2026
Independently accredited to global standards, ACTT’s IAoCR Gold Accreditation reflects our commitment to high-quality clinical research delivery.
Read more
11/12/2025
As the end of the year approaches, it is encouraging to reflect on ACTT’s strong performance across a broad range of therapeutic areas. Our involvement in cutting-edge research, including modern CRISPR therapies for rare diseases and inherited cholesterol disorders, and next generation of triple agonists in the metabolic space – continues to put Aotearoa on the map.
Read more
15/10/2025
We are proud to introduce our 2025 Annual Report highighting the work and outcomes of the last year.
Read more
19/08/2025
The New Zealand BALANCE+ Team is hosted by Aotearoa Clinical Trials at Middlemore Hospital. Together with researchers from Australia, Israel, Colombia, and Canada, they are contributing to the global BALANCE+ trial, hosted by the Sunnybrook Research Institute in Canada.
Read more
22/04/2025
The Surgical Trial Network – New Zealand has officially launched, marking a significant step forward in advancing surgical clinical research across Aotearoa.
Read more
